Paving the way globally in microbial efficacy, we have the most comprehensive portfolio of efficacy testing in ultrasound probe
high level disinfection (HLD).
We go further…
Nanosonics conducts extensive laboratory testing, focused on continually validating the effectiveness of trophon. Patient safety and reducing the risk of infection spread is paramount to us and drives our clinical research and testing.
Going far beyond the minimum regulatory requirements, we prioritise having the broadest possible microbial efficacy program. This absolute dedication to going further really sets us apart and ensures we exceed standards in HLD.
trophon is a pioneer globally in microbial efficacy, the first HLD system in the world proven to kill native, infectious, high-risk HPV.1
- trophon inactivates the mandated subset of microorganisms, as required by European Standards.
- trophon is proven to also eliminate an extended range of clinically infectious pathogens that other HLD products do not, including:*
– Sexually Transmitted Infections (STIs)
– Clostridium difficile spores
– Drug resistant bacteria
Sexually Transmitted Infections (STIs) testing
Ultrasound probes frequently contact body sites where STIs can occur. trophon is proven to completely inactivate a range of STI causing pathogens.*
2. Taylor S, Bunge E, Bakker M, Castellsagué X. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infectious Diseases. 2016;16:293.
3. Public Health England. The surveillance, epidemiology, screening and prevention of chlamydia. Infectious Diseases Collection – Chlamydia: surveillance, data, screening and management. Updated 26 February 2016. https://www.gov.uk/government/collections/chlamydia-surveillance-data-screening-and-management#epidemiology. Accessed 16 Mar 2017.
4. Public Health England. HIV diagnoses, late diagnoses and numbers accessing treatment and
care: 2016 Report. Version 1. Published October 2016.
5. Terrence Higgins Trust, HIV in the UK. http://www.tht.org.uk/our-charity/Facts-and-statistics-about-HIV/HIV-in-the-UK. Accessed 19 Apr 2017.
6. Public Health England. Acute hepatitis B (England): annual report for 2015. Health Protection Reports – Infection Reports/Immunisation. Vol. 10 No. 28. 26 August 2016.
7. Public Health England/Health Protection Scotland/Public Health Wales/HSC. Hepatitis C in the UK: 2016 Report. Working towards its elimination as a major public health threat. Published July 2016. PHE publications gateway number: 2016151.
8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology. 1999;189(1):12-9.
9. NHS Choices. What is HPV? NHS Choices – Common Health Questions. Updated 15 December 2015. http://www.nhs.uk/chq/pages/2611.aspx. Accessed 15 Mar 2017.
10. Public Health England. Sexually transmitted infections and chlamydia screening in England, 2015. Health Protection report (weekly report): Infection report. Vol 11 No. 20. 9 June 2017.
11. European Centre for Disease Prevention and Control. Annual epidemiological report 2014. Antimicrobial resistance and healthcare-associated infections. Stockholm: ECDC; 2015. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-annual-epidemiological-report.pdf. Accessed 17 Mar 2017.
* Nanosonics internal test data.
Bacterial spores testing
Bacterial spores are extremely resistant to disinfectants. In addition to achieving high level disinfection, trophon is effective against bacterial endospores in accordance with European Standards. trophon is effective against Clostridium difficile spores which contribute significantly to the Hospital Acquired Infection burden and cause severe diarrhoea in infected individuals.
Drug resistant bacteria testing
Drug resistant bacteria outbreaks in healthcare facilities are a real threat and antibiotics are ineffective against these strains. trophon inactivates these drug resistant bacteria.*
2. Rubin ZA, Murthy RK. Outbreaks associated with duodenoscopes: new challenges and controversies. Curr Opin Infect Dis. 2016;29(4):407-14.
3. O’Horo JC, Farrell A, Sohail MR, Safdar N. Carbapenem-resistant Enterobacteriaceae and endoscopy: An evolving threat. Am J Infect Control. 2016; 44(9):1032-6.
* Nanosonics internal test data.
European Standard Testing Requirements
trophon is shown to inactivate all the mandated microorganisms with its seven-minute cycle time when tested according to European Standards. trophon exceeds the minimum requirements for high level disinfection.
|Carbapenam-resistant Escherichia coli||Candida albicans|
|Enterococcus hirae||Aspergillus niger|
|Methicillin-resistant Staphylococcus aureus||Viruses|
|Pseudomonas aeruginosa||Hepatitis C virus surrogate (Bovine viral diarrhoea virus)|
|Staphylococcus aureus||Human hepatitis B virus surrogate (duck hepatitis B virus)|
|Vancomycin-resistant Enterococcus||Human immunodeficiency virus type 1|
|Mycobacteria||Human papillomavirus (HPV16 and HPV18)|
|Mycobacterium terrae||Polio virus|
|Bacterial endospores||Chlamydia trachomatis|